PO.5.102 Pharmacokinetic modelling of belimumab in patients with lupus nephritis: intravenous and subcutaneous loading dose regimen justification

Autor:	I Parodis, L Liefaard, Y Green, JA Gilbride, C Henning, RA Levy, R Dimelow
Rok vydání:	2022
Zdroj:	Friday 07 October 2022 from 13:00 to 14:10.
DOI:	10.1136/lupus-2022-elm2022.126
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::780c0c8c1970eb91aaae854df6b265f4 https://doi.org/10.1136/lupus-2022-elm2022.126 Zobrazit plný text záznamu